Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05802615
Other study ID # 0076-23-EP
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 6, 2023
Est. completion date October 31, 2024

Study information

Verified date September 2023
Source University of Nebraska
Contact Elizabeth K Mollard, PhD
Phone 402-472-3665
Email elizabeth.mollard@unmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. PARITY is a program that provides community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths (referred to as protective assets) through positive messaging and by promoting wellness.


Description:

The overall objective of this study is to determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. PARITY is a program that provides community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths (referred to as protective assets) through positive messaging and by promoting wellness (sleep, physical activity, nutrition, prenatal care adherence) in Black pregnant women.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date October 31, 2024
Est. primary completion date April 29, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years to 51 Years
Eligibility Inclusion Criteria: - Black race - Pregnant with gestational age 20-28 weeks at enrollment - Ability to read and write in English language - Planning to give birth at a healthcare facility & receive obstetrical care with a healthcare record - Reside within 20 minutes of the Lincoln/Omaha, NE metro area - Owns a smartphone with internet access Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
PARITY
The PARITY program reinforces strengths through consistent, community-based Black doula support and protective asset (personal strengths) focused messaging. PARITY promotes wellness-related behaviors (nutrition, physical activity, sleep, and healthcare adherence) and promotes and builds empowered strengths (self-efficacy, social support, motivation, resilience, problem-solving, and self-regulation) through mobile technology and doula support.
Other:
Usual Care
Participants will obtain prenatal care from their usual care provider and a handout on healthy pregnancy.

Locations

Country Name City State
United States University of Nebraska Medical Center Omaha Nebraska

Sponsors (1)

Lead Sponsor Collaborator
University of Nebraska

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Nutritional Intake Nutritional intake will be measured with the Multifactor Screener, 2000 as used in the Observing Protein and Energy Nutrition (OPEN) Study. This instrument measures approximate intakes of fruits and vegetables, percentage energy from fat, and fiber. Respondents report how frequently they consume foods in 16 categories and type of milk consumed. Baseline, 6-12 weeks postpartum
Other Physical Activity Physical activity will be measured with the International Physical Activity Questionnaire short-form (IPAQ-SF). The IPAQ-SF consists of 9 items and provides information on the time spent walking, in vigorous and moderate intensity activity and in sedentary activity. Baseline, 6-12 weeks postpartum
Other Sleep quality Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI. The PSQI is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score. Baseline, 6-12 weeks postpartum
Other Healthcare Adherence Healthcare adherence will be measured by number of healthcare appointments measured in the medical record. Pregnancy continuum, measured at 12 weeks postpartum retrospectively via the medical record
Other Self-efficacy Self-efficacy will be measured using the GSE General Self Efficacy (GSE) Scale: The GSE is a one-dimensional self-report measure that features a 10-item questionnaire assessing the optimistic self-beliefs of individuals to cope with a variety of difficult demands in life. The response options are presented along a 4-point Likert scale for each item. Baseline, 6-12 weeks postpartum
Other Social support Social support will be measured with the 10 item Social Provisions Scale (SPS-10). The SPS-10 assesses five forms of social provisions: attachment, guidance, social integration, reliable alliance, and reassurance of worth. Each item is rated on a four-point Likert scale. Baseline, 6-12 weeks postpartum
Other Problem-solving Problem solving will be measured with the Problem-Solving Inventory (PSI). The PSI measures how well individuals make decisions and their problem-solving abilities. The PSI includes 32 items using a 6-point Likert scale. Baseline, 6-12 weeks postpartum
Other Motivation Motivation will be measured with the Self-Motivation Inventory (SMI). The SMI is a 40 item 5 point Likert scale. Baseline, 6-12 weeks postpartum
Other Resilience Resilience will be measured using the 10 item Connor-Davidson Resilience Scale (CD-RISC 10). The CD-RISC 10 a unidimensional self-reported scale consisting of 10-items measuring resilience. Respondents rate items on a 5-point Likert scale. Baseline, 6-12 weeks postpartum
Other Self-Regulation Self-Regulation will be measured with the index of self-regulation (ISR). The ISR is a nine-item scale that measures level of self-regulation for health behavior change. Respondents rate items on a 5-point Likert scale. Baseline, 6-12 weeks postpartum
Other Discrimination Discrimination will be measured using the Everyday Discrimination Scale (EDS). The EDS measures frequency of chronic and routine unfair treatment in everyday life. Respondents are asked to report how often they experience unfair treatment in their day-to-day life on a 6-point Likert scale. Baseline, 6-12 weeks postpartum
Other Neighborhood Neighborhood will be assessed using the Neighborhood Collective Efficacy - Community Cohesion and Informal Social Control protocol. This protocol includes 10 Likert-style questions from the Project on Human Development in Chicago Neighborhoods (PHDCN). The Social Cohesion and Informal Social Control subscales include five items each. Baseline
Other Acceptability and Experience Select intervention participants only (10-15). Qualitative interview to discuss acceptability and experience with the intervention. 12 weeks postpartum
Primary Maternal Blood Pressure Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110). 20 weeks
Primary Maternal Blood Pressure Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110). 36 weeks
Primary Maternal Blood Pressure Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110). Birth (approximately 36-42 weeks)
Primary Maternal Blood Pressure Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110). 6-12 weeks postpartum
Primary Feasibility, Enrollment Percentage of eligible individuals who agree to participate in the trial Baseline
Primary Feasibility, Attrition Percentage of eligible individuals who complete the data Completion of Study (~24 months)
Primary Feasibility, Adherence Number of intervention sessions completed by study participants Completion of Study (~24 months)
Secondary Gestational Weight Gain Amount of weight gained in pounds 20 weeks, 36 weeks, Birth, 6 weeks postpartum.
Secondary Delivery Modality Modality of birth (Vaginal, Cesarean, Assisted Vaginal delivery) Birth (approximately 36-42 weeks)
See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT05997303 - Continuous Norepinephrine Administration and Blood Pressure Stability During Anesthetic Induction N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT03918486 - Caretaker vs. Routine Blood Pressure Sphygmomanometer
Completed NCT03410342 - The Effects of Types of Fruits and Vegetables on Vascular Function N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT04087070 - Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
Completed NCT03294928 - Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers N/A
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03997461 - Comparison of Arterial Tonometry Sensor With Standard Oscillometric Blood Pressure Monitoring Device N/A
Completed NCT03290716 - Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China N/A
Recruiting NCT06460233 - Blood Pressure Changes After Bariatric Surgery
Recruiting NCT05196048 - Blood Pressure Sensor of Watch-type Device With ECG Technology
Terminated NCT03325933 - Resistance Training and Cardiometabolic Health N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02451059 - Reducing Socioeconomic Disparities in Health at Pediatric Visits N/A
Active, not recruiting NCT02670967 - Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials N/A
Completed NCT02271633 - Nitrate Supplementation; Source Phase 4
Completed NCT02239744 - Intervention Study on the Health Impact of Air Filters in Chinese Adults N/A